December 31, 2012

 

The Food and Drug Administration has granted accelerated approval for bedaquiline, the first tuberculosis drug to be developed in 40 years. Bedaquiline is "a potential game changer" in treating drug-resistant tuberculosis, according to Dr. Manica Balasegaram, executive director of MSF's Access Campaign.


View external media

Related News & Publications

Be part of MSF

Our supporters, donors, and fundraisers are a vital part of the MSF movement.

Find out how you can support MSF's lifesaving work.

Learn more